INSTANT: INtegrilin Plus STenting to Avoid Myocardial Necrosis Trial
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
Randomized, blind controlled, Multicenter, spontaneous, prospective trial, roughly 20
enrolling centers in Italy, placebo and active drug supply given by GlaxoSmithKline (GSK).
Phase:
Phase 3
Details
Lead Sponsor:
Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS Fondazione Mediolanum per Attività e Ricerche Cardiovascolari Onlus